{"nct_id":"NCT00145301","title":"52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine","status":"COMPLETED","status_verified_date":"2012-05","start_date":"2004-09","start_date_type":null,"primary_completion_date":"2005-11","primary_completion_date_type":"ACTUAL","completion_date":null,"completion_date_type":null,"phases":["PHASE3"],"tickers":["NVS"]}